STAAR Surgical Company - Common Stock (NQ:STAA)

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, and...

3 Healthcare Stocks Walking a Fine Line

January 18, 2026

STAAR Surgical’s 23.7% return over the past six months has outpaced the S&P 500 by 13.1%, and its stock price has climbed to $21.14 per share. This was partly due to its solid quarterly results, and...

Topics Stocks

STAAR Surgical (STAA): Buy, Sell, or Hold Post Q3 Earnings?

January 15, 2026

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to...

Topics Stocks

3 Stocks Under $50 That Fall Short

January 11, 2026

STAAR Surgical Stock Jumps 10% After Alcon Sweetens Buyout Offer — Investor Says Deal Is ‘Worth Substantially More’ ↗

Topics Economy

December 09, 2025

Staar Surgical Shares Slip After Alcon Refuses To Reconsider Merger Consideration ↗

October 31, 2025

STAAR’s results show a story about timing, cash discipline, and what happens when reported growth finally lines up with underlying demand.

Traders are paying attention to the gapping stocks in Tuesday's session. ↗

January 06, 2026

Via Chartmill

New $17 Million Bet on STAAR Surgical Comes as Sales Jump 7% and Margins Hit 82% ↗

December 30, 2025

Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.

Topics Regulatory Compliance

3 Low-Volatility Stocks We Keep Off Our Radar

December 28, 2025

What a $22 Million Bet on STAAR Surgical Signals After Third-Quarter Earnings and a 15% Market Lag ↗

December 23, 2025

The stock is roughly flat this past year, but the fundamentals quietly moved in the right direction, and that disconnect likely caught this fund’s attention.

STAAR Surgical Stock Rises After Adjournment Of Stockholders’ Meeting To Discuss Proposed Merger With Alcon ↗

Topics Regulatory Compliance

October 23, 2025

STAAR Surgical’s Shareholder Yunqi Capital Opposes Proposed Merger With Alcon – Here’s Why ↗

September 22, 2025

A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.

3 Cash-Heavy Stocks We Keep Off Our Radar

December 21, 2025

Shares of medical lens company STAAR Surgical (NASDAQ:STAA) jumped 3.9% in the morning session after the company issued a statement to defend its pending merger process with Alcon against claims from...

Why STAAR Surgical (STAA) Stock Is Up Today

December 11, 2025

Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these...

Topics Artificial Intelligence

1 Russell 2000 Stock Worth Investigating and 2 We Find Risky

December 10, 2025

Shares of medical lens company STAAR Surgical (NASDAQ:STAA) jumped 9.8% in the afternoon session after its merger partner, Alcon, increased its cash buyout offer for the company. Under the amended...

STAAR Surgical (STAA) Shares Skyrocket, What You Need To Know

December 09, 2025

Today's session on Tuesday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.

Traders are paying attention to the gapping stocks in Tuesday's session. ↗

December 09, 2025

Via Chartmill

Why STAAR Surgical (STAA) Shares Are Plunging Today

December 08, 2025

Shares of medical lens company STAAR Surgical (NASDAQ:STAA) fell 7.1% in the afternoon session after the company announced the expiration of its 'go-shop' period without receiving any competing...

STAAR Surgical (NASDAQ:STAA) Q3 Earnings: Leading The Medical Devices & Supplies - Specialty Pack

December 04, 2025

Looking back on medical devices & supplies - specialty stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including STAAR Surgical (NASDAQ:STAA) and its peers.

Healthcare Investor Exits $13 Million Stake STAAR Surgical Stake as Alcon Deal Drama Looms ↗

December 03, 2025

One specialist investor just walked away from STAAR Surgical entirely—right as uncertainty over a delayed Alcon deal looms.

Yunqi Capital Sells 130,000 Futu Holdings (FUTU) Shares Worth $16.1 Million

Topics Regulatory Compliance

Yunqi Capital Sells 130,000 Futu Holdings (FUTU) Shares Worth $16.1 Million ↗

November 23, 2025

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside...

3 Small-Cap Stocks That Fall Short

November 10, 2025

Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The flip side though is that these lofty expectations make them particularly...

2 High-Flying Stocks on Our Buy List and 1 We Find Risky

November 05, 2025

3 Stocks Under $50 We Keep Off Our Radar

November 04, 2025

Companies that burn cash at a rapid pace can run into serious trouble if they fail to secure funding. Without a clear path to profitability, these businesses risk dilution, mounting debt, or even...

1 Cash-Burning Stock for Long-Term Investors and 2 We Turn Down

October 31, 2025

A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face challenges like stagnating revenue, declining...

Topics Bankruptcy

1 Cash-Heavy Stock on Our Buy List and 2 Facing Challenges

October 27, 2025

Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk running out of capital...

3 Unprofitable Stocks We Approach with Caution

October 20, 2025

STAAR Surgical’s Long-Term Shareholder Says Proposed Deal With Alcon Undervalues The Company ↗

October 07, 2025

Defender Capital, which owns 1.5% of STAAR’s common stock, highlighted STAAR’s board of directors' rejection of Alcon's previous offer of $58 per share in cash.

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other...

3 Unpopular Stocks We Think Twice About

October 06, 2025

STAAR Surgical has been on fire lately. In the past six months alone, the company’s stock price has rocketed 52.2%, reaching $26.75 per share. This was partly thanks to its solid quarterly results, and...

3 Reasons to Avoid STAA and 1 Stock to Buy Instead

September 26, 2025